To confirm the results from pharmacological PIM1 blocking, the protein expression of the most accepted GBM stem cell markers Nestin and CD133 were investigated after siRNA-mediated knockdown of PIM1 in adherent LN-18 cells. This evidence concerns the gene NES and glioblastoma.